Saturday, May 09, 2026 7:36:42 AM
One clarification on the $720K estimate. That appears to use the older 9/30/25 10-Q current-assets number of about $7.2M. The more current filed balance sheet is NWBO’s 2025 10-K for the year ended 12/31/25, filed April 15, 2026. In the Consolidated Balance Sheets, NWBO lists total current assets of $5.517M.
So, using the 10% current-assets reference point under the legal-proceedings disclosure framework, the rough number would be $552K, not $720K.
Also, the 10-Q is not the only reporting requirement. A material settlement could trigger Form 8-K current reporting before the next quarterly filing. If the Canaccord settlement agreement was a material definitive agreement, the trigger would generally be when the agreement was entered into. Under Form 8-K, most triggering events must be reported within four business days, so if the agreement was signed, binding, and material, the clock would generally start then.
Also, confidentiality and strategy may affect how much detail NWBO wants to disclose, but they do not eliminate disclosure obligations if the settlement is material. NWBO may have strategic reasons to prefer silence, especially with Citadel, Virtu, and Susquehanna still in the case. If the amount is small, disclosing it could weaken settlement leverage. If the amount is large, disclosing it could affect the remaining defendants’ strategy. In the end, materiality controls reporting, not strategic silence.
How well do you think the billion dollar jackpot fantasy is holding up now?
So, using the 10% current-assets reference point under the legal-proceedings disclosure framework, the rough number would be $552K, not $720K.
Also, the 10-Q is not the only reporting requirement. A material settlement could trigger Form 8-K current reporting before the next quarterly filing. If the Canaccord settlement agreement was a material definitive agreement, the trigger would generally be when the agreement was entered into. Under Form 8-K, most triggering events must be reported within four business days, so if the agreement was signed, binding, and material, the clock would generally start then.
Also, confidentiality and strategy may affect how much detail NWBO wants to disclose, but they do not eliminate disclosure obligations if the settlement is material. NWBO may have strategic reasons to prefer silence, especially with Citadel, Virtu, and Susquehanna still in the case. If the amount is small, disclosing it could weaken settlement leverage. If the amount is large, disclosing it could affect the remaining defendants’ strategy. In the end, materiality controls reporting, not strategic silence.
How well do you think the billion dollar jackpot fantasy is holding up now?
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
